Latest Regulatory News

3D Energi Limited has updated its prospective gas resource estimates in the Otway Basin, revealing a substantial 9.2 trillion cubic feet (Tcf) of gross recoverable gas across 51 prospects. The company is gearing up for a multi-well drilling campaign in 2025 targeting near-term commercialisation opportunities to bolster East Coast energy security.

Kinterra has increased its takeover offer for New World Resources to A$0.062 per share, positioning its bid as superior and less conditional than rival Central Metals Asia’s scheme proposal. With a significant stake and strategic moves underway, the battle for NWR ownership intensifies.

Alligator Energy has completed a $17.25 million placement to fund critical development and exploration activities at its Samphire Uranium Project in South Australia, setting the stage for key milestones through 2026.

SciDev Limited has secured $21.5 million in new contracts and renewals across oil & gas, mining, and PFAS remediation sectors, boosting its FY26 revenue guidance to $120-$140 million.

Osmond Resources has significantly expanded its Orion EU Critical Minerals Project in Southern Spain by 160%, adding three new permits and preparing for a targeted drilling campaign to confirm mineral continuity.

Burley Minerals reports encouraging assay results from its maiden drilling at the Cane Bore South Target, confirming surface and near-surface iron mineralisation with high-grade intercepts. The company plans further exploration at larger adjoining targets in the Pilbara region.

Gateway Mining Limited has agreed to acquire Strickland Metals’ Yandal Gold Project for $45 million in shares, adding a 400,400-ounce inferred gold resource to its portfolio. The acquisition, pending shareholder approvals, positions Gateway for significant exploration and development in Western Australia’s prolific goldfields.

QPM Energy Limited has launched the Isaac Energy Hub with its first stage, a 112MW gas-fired power station, aiming for mid-2027 commissioning. The company is raising $12 million to support project development and expand its integrated energy utility footprint.

Cambium Bio has secured ethics approvals in Australia and the US to initiate pivotal Phase 3 trials of Elate Ocular, targeting moderate to severe dry eye disease, with patient dosing expected in October 2025.

South Harz Potash Ltd has announced a pro-rata non-renounceable entitlement issue to raise approximately A$1.28 million, offering one new share for every three held plus free options. The capital raise aims to fund its dual-asset growth plans in Germany amid ongoing project development and acquisition efforts.

Actinogen Medical has locked in up to $13.8 million in non-dilutive funding tied to its R&D tax incentives, bolstering its cash position as it advances a pivotal Alzheimer’s disease clinical trial.

Green Critical Minerals’ McIntosh Graphite Project Pre-Feasibility Study confirms robust economics with a post-tax NPV of A$235 million and a 32.5-year mine life, underpinning plans for staged development and market entry.